NCI - National Cancer Institute
Project Summary We propose to advance next-generation cancer vaccines with superior immunogenic payloads for KRAS mutations, building upon the safety and proven efficacy of the mRNA-LNP platform for vaccine delivery. The totality of results from our proposal will advance preclinical optimization of a next-generation, lead vaccine, supporting IND submission and thoughtful advancement into clinical trials. We will focus on KRAS mutations because of their prevalence in pancreatic cancer, which is an indication with a poor prognosis with limited therapeutic modalities. We will characterize the immunogenicity of our novel vaccine products and evaluate the cross-reactivity of the T cell responses they prime that recognize tumor presented neoepitopes (Aim 1). We will perform this work by sequencing T cell receptors in mouse models containing humanized HLA alleles. Our approach has been enabled by the development of programmable mRNA vaccine platforms and new computational methods.
Up to $406K
2026-08-31
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
One-time $749 fee · Includes AI drafting + templates + PDF export
Dynamic Cognitive Phenotypes for Prediction of Mental Health Outcomes in Serious Mental Illness
NIMH - National Institute of Mental Health — up to $18.3M
COORDINATED FACILITIES REQUIREMENTS FOR FY25 - FACILITIES TO I
NCI - National Cancer Institute — up to $15.1M
Leveraging Artificial Intelligence to Predict Mental Health Risk among Youth Presenting to Rural Primary Care Clinics
NIMH - National Institute of Mental Health — up to $15.0M
Feasibility of Genomic Newborn Screening Through Public Health Laboratories
OD - NIH Office of the Director — up to $14.4M
WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL COORDINATING CENTER - TASK AREA A AND A2
NHLBI - National Heart Lung and Blood Institute — up to $10.2M
Metal Exposures, Omics, and AD/ADRD risk in Diverse US Adults
NIA - National Institute on Aging — up to $10.2M